ArticleScientific reports2025
Assessing resilience in pharmacy education during the COVID-19 era.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In higher education, resilience is vital for enabling students and academics to confront challenges and sustain well-being. The COVID-19 pandemic has amplified concerns about how individuals in higher education, including in pharmacy education, adapt to drastic shifts in societal, economic, and educational contexts. This study aimed to explore resilience in pharmacy higher education within the Eastern Mediterranean Region. This cross-sectional study was conducted from October 2020 to January 2021, involving pharmacy students and academics across the 22 EMR countries. Data collection utilised an online questionnaire, that included, along with demographic and environmental items, the CD-RISC-22 scale, a modified version of the Connor Davidson Resilience Scale (CD-RISC-25). CD-RISC-22 is a 22 items, a self-administered psychometric scale, tailored to assess resilience among pharmacy students and academics in EMR region. Data were analysed using descriptive and comparative statistical methods. Students exhibited a significantly lower resilience scores (mean ± SD: 58.81 ± 13.41) when compared with academic staff/faculty (66.74 ± 10.29) across all constructs of the CD-RISC-22 scale (p < 0.000), with the exception of the 'connection/spirituality' factor (p = 0.1). The availability of mental health support services in educational institutions was found to be limited, with only 13 (10.7%) academic respondents reporting access to a mental health advisory scheme and 88 (17.7%) of students reporting access to mental health and well-being support training. Academics and students felt more supported by their colleagues and peers than by their institutions. This research sheds light on the variations in resilience levels between pharmacy students and academics in the EMR, emphasising the need for targeted interventions to enhance undergraduate students' resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.